The Impact of Acute Trans-resveratrol Administration on Whole Body Metabolism During Cognitive Demand.

NCT03546075 | Completed

• 1 other identifier: 42BB1
• Study Type: interventional
• Target: 27
• Locations: 0 countries
• Sites: N/A

Brief Summary

Background: Increased cerebral vaso-dilation during cognitive demand is hypothesised to improve cognitive performance due to an improved micronutrient status. Despite previous research demonstrating that oral resveratrol can modulate cerebral haemodynamics, this has not translated into expected improvements to cognitive performance in young, healthy populations. As the brain is the most metabolic organ in the body, even subtle changes to fuel utilization and overall energy expenditure are detectable during cognitive demand. The measurement of both overall energy expenditure and fuel utilization may provide further insight to the effects of resveratrol and whether oral supplementation of this polyphenol can provide clear, cognitive benefits in a young, healthy sample. Objectives: The current study investigated the metabolic consequences of resveratrol on whole body metabolism and fuel oxidisation during cognitive performance. Methods: This repeated measures, double blind, placebo controlled, balanced design required participants (N=24 for metabolic activity \& N=26 for cognitive outcomes) to complete a serial subtraction demand battery at baseline, 45 minutes, 2 and 3 hours following 500 mg, 250 mg trans-resveratrol or inert placebo, on three separate occasions whilst connected to an on-line gas analysis system.

Conditions

Cognitive Change

Keywords

Cognition; Resveratrol; Whole body metabolism

Outcome Measures

Primary Outcomes (3)

• Cognitive performance

  Participants completed three Serial subtraction tasks (Serial 3, 7 \& 17). Outcomes measured from all three of these tasks were the number correct entries and number of errors. The addition of the two outcomes can also provide a 'total' number of responses entered.

  1 Hour

• Whole body metabolism

  Whole body energy expenditure was measured via indirect calorimetry and was reported in calories burned per minute (Kcal / min).

  1 Hour

• Fuel Oxidisation

  Fuel oxidation was measured via indirect calorimetry and examined the rate of carbohydrate and fat oxidisation (both in grams per minute (g / min)).

  1 Hour

Secondary Outcomes (1)

• Pulmonary gases

  1 Hour

Study Arms (3)

500 mg Resveratrol

EXPERIMENTAL

Dietary Supplement: Resveratrol

250 mg Resveratrol

EXPERIMENTAL

Dietary Supplement: Resveratrol

Placebo

PLACEBO COMPARATOR

Other: Placebo

Interventions

Resveratrol DIETARY_SUPPLEMENT

250 mg Resveratrol; 500 mg Resveratrol

Placebo OTHER

Placebo

Eligibility Criteria

• Age: 18 Years - 35 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Participants who were able to give informed consent.

You may not qualify if:

• Those who took hormonal contraception (e.g. the pill, coil, implant, etc.) were still allowed to participate in the current study.
• Participants who smoke.
• Participants below the age of 18 years or above 35 years at the time of giving consent to in role in the current study.
• Participants with Body Mass Index outside the range of 18-35 kg/m2.
• Participants with blood pressure greater than 140/90 HH/mg.
• Participants with a history of neurological, vascular or psychiatric illness (excluding depressive illness and anxiety).
• Participants with a current diagnosis of depression and / or anxiety.
• Participants with learning difficulties: dyslexia, dyscalculia or colour blindness.
• Participants with a visual impairment that cannot be corrected with glasses or contact lenses.
• Participants with frequent migraines that require medication (more than or equal to 1 per month).
• Participants with disorders of the blood.
• Participants with a heart disorder.
• Participants with diabetes.
• Participants with a respiratory disorder that requires regular medication (Note: asthma sufferers who only take their medication occasionally/as required were eligible for this study).
• Participants currently taking any prescription medications.

Sponsors & Collaborators

• Northumbria University: lead

MeSH Terms

Interventions

Resveratrol

Intervention Hierarchy (Ancestors)

Stilbestrols; Stilbenes; Benzylidene Compounds; Benzene Derivatives; Hydrocarbons, Aromatic; Hydrocarbons, Cyclic; Hydrocarbons; Organic Chemicals; Polyphenols; Phenols

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Purpose: BASIC SCIENCE
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principal investigator

Study Record Dates

• First Submitted: April 9, 2018
• First Posted: June 6, 2018
• Study Start: May 7, 2015
• Primary Completion: December 18, 2015
• Study Completion: December 18, 2015
• Last Updated: June 6, 2018

Record last verified: 2018-06